baber/WOPTO huggingface dataset:
Patent DE-60103066-T2 (DE)
Inventor: KRALOVEC A
IPC: A23L35/00
Filed: 2001-08-09
Granted: 2005-04-28
Abstract: Chlorella extracts containing high molecular weight Chlorella polysaccharide and polysaccharide complexes show immune modulatory, specifically immune stimulatory, activity. The polysaccharide and polysaccharide complexes contain glucose and any combination of: galactose, rhamnose, mannose and arabinose, as well as N-acetyl glucosamine and N-acetyl galactosamine. The extracts may be treated with pronase, DNAse, RNAse and proteases to remove unassociated nucleic acids, ribonucleic acids and proteins. The extracts may also undergo treatment to effect cleavage of specific glycosidic linkages, the linkages being defined by their susceptibility to cleavage by amylase, amyloglucosidase, cellulase or neuraminidase. Chlorella extracts may be administered to a mammal to increase proliferation of splenocytes and increase production of cytokines such as IL-6, IL-10, INF-gamma and TNF-alpha. They may be used as a supplement to a vaccination regimen.
Patent DE-60104380-T2 (DE)
Inventor: CHEN CHONG-MING
IPC: C07C271/22
Filed: 2001-10-15
Granted: 2006-05-24
Abstract: A process for preparing N-[1- (S)-ethoxycarbonyl-3-phenylpropyl]-L-alanine N-carboxyanhydride of the following formula (I), is to react N-[1-(S)-ethyoxy carbonyl-3-phenylpropyl]-L-alanine with XCOOR, wherein X is halogen atom, R is C<sub>1</sub>-C<sub>6</sub> alkyl, to obtain a N-alkoxycarbonyl compound, then reacting with an acyl group activation reagent, finally contact with water. The compound of formula (I) is a key intermediate of ACE inhibitors.
Patent DE-60105604-T2 (DE)
Inventor: STOEVER HARALD D H
IPC: B01J13/16
Filed: 2001-06-11
Granted: 2005-11-10
Abstract: Microcapsules or particles of a matrix are formed by interfacial reaction between reactants that can form a membrane, one of the reactants comprising anhydride moieties. These can be used to encapsulate materials, particularly materials for controlled release. Examples include pheromones that are slowly released during the breeding season of insects to control the insect population.
Patent DE-60106477-T2 (DE)
Inventor: GUIMARD BRUNO
IPC: B60B21/00
Filed: 2001-10-31
Granted: 2006-02-02
Abstract: A method of making a rim of sheet metal for a vehicle wheel, in which: a rectangular geometric shape is cut out of a blank of sheet metal; the blank is bent to obtain a cylindrical hoop; the two free edges of the hoop are welded together; at least one cylindrical flow spinning operation is performed to obtain a profile of given thickness of the hoop, zones of constant thickness being adjacent to zones of variable thickness; a cut is made perpendicular to the axis of the hoop out of at least one lateral edge of the hoop; the hoop is profiled to obtain the rim; and the size of the said rim is set.
Patent DE-60106748-T2 (DE)
Inventor: LAKE PHILIP
IPC: A61K35/38
Filed: 2001-04-12
Granted: 2005-10-27
Abstract: Thy-marrow composite tissue construct and composite organ for creating hematopoietic chimersim and inducing long-term stable immunological tolerance in a transplant recipient, especially a human xenotransplant recipient of a non-human mammalian (e.g. pig) organ. <IMAGE>
Patent DE-60107935-T2 (DE)
Inventor: YARBOROUGH L
IPC: A61M5/315
Filed: 2001-03-27
Granted: 2005-12-15
Abstract: A syringe assembly is provided which includes a hollow barrel that has an interior wall. The interior wall defines a chamber that retains medication. The hollow barrel also includes a distal end and a proximal end. The distal end of the hollow barrel has a passageway that is in contact with the chamber. The proximal end of the hollow barrel has an aperture. The syringe assembly also includes a primary plunger tip that is slidably positioned, in fluid tight engagement, with the interior wall. The primary plunger tip has a receptor to engage an engager of an elongated tip plunger rod. The syringe assembly also includes a secondary plunger tip that is slidably positioned, in fluid tight engagement, with the interior wall. The secondary plunger tip also has a receptor to engage an engager of a tip plunger rod. The secondary plunger tip is disposed between the primary plunger tip and the proximal end of the hollow barrel. The syringe assembly also includes a tip plunger rod, which facilitates operation of the secondary plunger tip, engaged to the secondary plunger tip. The present invention also provides a process for providing a lyophilized medication (i.e., lyophilizate) in a syringe assembly and also provides a process for reconstituting a medication in a syringe assembly.
Patent DE-60108486-T2 (DE)
Inventor: NIHLSTRAND ANNA
IPC: D06M11/77
Filed: 2001-02-02
Granted: 2006-01-12
Abstract: A fibrous structure testable in a series of run-off tests, wherein each run-off test includes exposing the fibrous structure to a volume of a test solution and the fibrous structure initially is hydrophobic and has been treated to be hydrophilic, wherein the fibrous structure exhibits a run-off level that is less than 5 percent by weight throughout a series of run-off tests, and wherein the series starts with a first run-off test and ends with a fifth run-off test.
Patent DE-60116226-T2 (DE)
Inventor: DREANO CLAUDE
IPC: A22C7/00
Filed: 2001-10-17
Granted: 2006-08-31
Abstract: The assembly consists of a series of moulds on a supporting frame (5, 6), each mould comprising a U-section trough (2) with a base (3) and side walls (4) which have their upper edges (7) turned outwards and welded together or to the frame. The edges have cut-out sections (8) along the weld lines (9) to create thermal channels (10). The bases of the troughs have covers (13) on their undersides to exert a pressure on moulds beneath them.
Patent DE-60127140-T2 (DE)
Inventor: PAI SRIKANTH A
IPC: A61K31/7048
Filed: 2001-06-19
Granted: 2007-12-13
Abstract: Parenteral compositions of oil-coated-Amphotericin B in structured-emulsion form, having LD50 of at least 400 mg/kg in mice and process for making the same have been described. The process essentially requires dispersing Amphotericin B in oily vehicle and dispersing emulsifier in the aqueous phase. The process of present invention is simple, cost effective and gives a stable product suitable for parenteral administration. Amphotericin B emulsion compositions prepared by the process of the present invention may be administered to human beings and animals for the treatment of fungal infections, with substantially equivalent or greater efficacy and low drug toxicity as compared to the conventional composition containing Amphotericin B and sodium desoxycholate.
Patent DE-60127402-T2 (DE)
Inventor: AUBERTON-HERVE ANDRE
IPC: H01L27/12
Filed: 2001-06-15
Granted: 2007-11-29
Abstract: Techniques are shown in which substrates having a first layer of a first material and second layer of a second material, wherein the second material is less noble than the first material, is provided by bonding the first and second layers together with an amorphous layer interposed there between. The amorphous material may be deposited on a bonding face of the first layer, second layer, or both, before the operation of bonding the first and second layers. The layer with less noble material may be a supporting layer and the other layer may be an active layer for forming components in optics, electronics, or opto-electronics. The amorphous layer may be polished before the bonding operation.
Patent DE-60202970-T2 (DE)
Inventor: BARKOCZY J ZSEF
IPC: A61K31/501
Filed: 2002-09-26
Granted: 2006-02-16
Abstract: The invention relates to substituted alkylaminopyridazinone derivatives of the general Formula (I), (wherein R<SUB>1 </SUB>is hydrogen or alkyl having 1-4 carbon atoms; one of X and Y stands for hydrogen or halogen and the other represents a group of the general Formula (II), R<SUB>2 </SUB>is hydrogen or alkyl having 1-4 carbon atoms; n is 1, 2 or 3; R<SUB>3 </SUB>stands for hydrogen, alkyl having 1-4 carbon atoms or aryl-(C<SUB>1-4 </SUB>alkyl); Z stands for oxygen; or R<SUB>3 </SUB>and Z together with the groups placed between them form a piperazine ring; and R<SUB>4 </SUB>stands for hydrogen, halogen, trifluoromethyl or alkoxy having 1-4 carbon atoms) and pharmaceutically acceptable acid addition salts thereof. The invention compounds are useful in the treatment of anxiolytic conditions and cognitive disorders.
Patent DE-60206278-T2 (DE)
Inventor: ABENDROTH TORSTEN
IPC: H04L7/00
Filed: 2002-07-03
Granted: 2006-07-06
Abstract: A status indication detection apparatus (SIDM) comprises an input storage stage (INS), an intermediate storage stage (ISS) and an output storage stage (OSS). Status indications (IN_STATUS) are input into the input register (INM) of the input stage (INS) and are shifted to the intermediate and to the output stage (ISS; OSS). The input and intermediate storage stages operate with a first reference clock (CLK_A) in a first clock domain (A) whilst the output storage stage operates with a different second reference clock (CLK_B) in the second clock domain (B). In accordance with the invention a reading out of the intermediate register (INT) of the intermediate stage (ISS) is only possible during the generation of a hold signal (LOCK) which keeps a current status indication in the intermediate storage stage (ISS) and blocks a transfer of a new status indication from the input stage (INS). Since the hold signal (LOCK) duration covers at lest one second clock reference period, a read out pulse (STROBE) can be placed within the hold signal duration (LOCKL). Thus, even at different phase and /or frequency relationships between the first and second reference clock (CLK_A, CLK_B) a metastability in the output register (ORM) can be avoided and no status indications output from the hardware device (HW) get lost. <IMAGE>
Patent DE-60208787-T2 (DE)
Inventor: KAELLANDER CLAS
IPC: C12Q1/6834
Filed: 2002-06-14
Granted: 2006-11-02
Abstract: A method for measuring DNA-dependent DNA polymerisation in a biological sample, is described. The method comprises the steps of providing a primer with a single stranded short specific sequence, which is unable to base pair internally, bound to a solid phase; contacting the primer construct with a reaction mixture containing a single stranded deoxynucleotide template with a part of the sequence complementary to the primer and the four deoxynucleoside triphosphates, one of which is modified so that it is specifically recognized by a labeled antibody; adding a biological sample comprising the DNA polymerase, such as retrovirus reverse transcriptase (RT), to the mixture; allowing the polymerase reaction to proceed; incubating the immobilized reaction product with the labeled antibody; detecting the amount of bound labeled antibody; and measuring the amount of incorporated modified deoxynucleoside triphosphate, as a measure of the DNA polymerisation, which may be used drug susceptibility testing. A commercial package is also disclosed.
Patent DE-60210108-T2 (DE)
Inventor: TIRMIZI ABRAR
IPC: F42B3/04
Filed: 2002-07-03
Granted: 2006-10-12
Abstract: A pyrotechnic initiator with enclosed on-board control circuitry, and a mating connector therefor.
Patent DE-60211917-T2 (DE)
Inventor: MAECKE ROBERT
IPC: A61K38/00
Filed: 2002-08-07
Granted: 2007-01-18
Abstract: The present invention relates to novel somatostatin analogues of the general formula: <CHEM> wherein Z may be absent or present and when present is selected from the group consisting of DOTA- and DTPA-based chelators, NOTA-based chelators, carbonyl compounds, hydrazino nicotinamide (hynic) , N4 -chelators, desferrioxamin, NxSy-chelators, all optionally complexed or labeled with a radioisotope, Tyrosine (Tyr) for halogenation, a fluorescent dye or biotin; L may or may not be present and is a linker molecule; X1 is a symmetric or asymmetric diamino acid, containing 3 or 4 consecutive C atoms with a linker to the chelating agent, for example D/L-diamino butyric acid (D/L-Dab) for a more basic character or D/L-Glu for coupling to primary and secondary amino groups; X2 is a positively charged natural or unnatural amino acid or arginine mimic or citrulline, or a neutral amino acid like Asn; X3 is phenylalanine (Phe), Ala- Ä3- (2-thienyl) Ü or  alpha '-, beta -naphthylalanine; X4 is an aromatic amino acid, optionally halogenated, in particular with Cl, Br, I or <18>F.; X5 is threonine (Thr) or serine (Ser); and X6 is phenylalanine (Phe), Ala-Ä3 -(2-thienyl)Ü Ü or  alpha -, beta -naphthylalanine.
Patent DE-60212917-T2 (DE)
Inventor: NAMBU KYOJIRO
IPC: G06T7/00
Filed: 2002-10-14
Granted: 2007-03-01
Abstract: First time-density curves concerning arteries in a specific region and second time-density curves concerning tissues in the specific region are prepared from a plurality of continuous images concerning the specific region of a subject into which a contrast medium is injected (S6, S11). Modulation transfer functions indicating local blood flow circulations in the tissues with respect to the arteries are calculated by curve-fitting so that residual errors of the second time-density curves are minimized with respect to convolution of the modulation transfer functions and first time-density curves (S12). Indices concerning the local blood flow circulations with respect to the respective arteries are calculated from the modulation transfer functions (S13). Maps of the indices for the arteries are prepared (S16), and the maps of these indices are synthesized into one map in accordance with the residual errors for the first time-density curves (S17). <IMAGE>
Patent DE-60220882-T2 (DE)
Inventor: DE GRAAUW ANTONIUS J
IPC: H01Q5/10
Filed: 2002-02-13
Granted: 2008-02-28
Abstract: The apparatus (100) comprises a printed circuit board (20) on which an antenna device (10) is present. The antenna (2) of the antenna device (10) can be tuned by means of matching bridges (34, 37), each of which comprise a reactive component (3,4) and a switch (25, 26). Preferably, the switches (25,26) are located outside the antenna device (10) such that a standardized antenna device (10) can be used.
Patent DE-60302666-T2 (DE)
Inventor: LAIGNEAU GILLES
IPC: A47J31/06
Filed: 2003-07-11
Granted: 2006-08-10
Abstract: The invention concerns a cartridge-operated coffee-machine, comprising means for supplying hot water to an infusion head adapted to receive at least two different cartridges ( 2, 2 ') including each at least one planar seat surface, means for communicating said supply means with the product contained inside the cartridges so as to obtain a beverage, and means for directing said beverage exiting from the cartridge towards a beverage collecting receptacle, where the infusion head comprises a support ( 11 ) having at least one pocket ( 29 ) forming a housing for at least two different cartridges ( 2, 2 '). The invention is characterized in that said pocket ( 29 ) comprises a single peripheral seat ( 35 ) common to several cartridges ( 2, 2 ') of different seat diameters, one or more portions of the outer rim of said peripheral seat 835 forming an indexing vertical wall common to said cartridges ( 2, 2 ').
Patent DE-60303765-T2 (DE)
Inventor: TAKAHASHI TORU
IPC: G06F13/00
Filed: 2003-12-10
Granted: 2006-09-21
Abstract: To provide a device monitoring system, device monitoring program, and device monitoring method which can monitor device status quickly without increasing the load on device management servers or increasing network traffic.  Devices 10 connected to a network N are provided with a device monitoring function 20 for monitoring another device 10 and notifying a device management server 12 or a third device 10 of any abnormality. This eliminates the need for periodic interrogations of devices 10 by the device management server 12 and responses from the devices 10 unlike conventional schemes, and thus avoids increases in the load on the device management server 12 and in network traffic even if the number of devices 10 increases.
Patent DE-60306201-T2 (DE)
Inventor: GALIMBERTI MAURIZIO
IPC: B29C48/30
Filed: 2003-12-01
Granted: 2007-04-26
Abstract: A method for reducing elongational viscosity of an elastomeric composition includes adding at least one elongational-viscosity-reducing additive to the elastomeric composition in an amount so that the elongational viscosity of the elastomeric composition, measured at 120° C. and at a shear rate of at least 1000 sec<SUP>-1</SUP>, is at least 10% less than the elongational viscosity, measured at 120° C. and at the shear rate of at least 1000 sec<SUP>-1</SUP>, of the elastomeric composition without the at least one additive. A process for producing a tyre includes feeding an elastomeric composition to an extruder; forming, by extrusion, the elastomeric composition as a continuous elongated element; and depositing the elongated element on a support in a plurality of coils to make up a structural element of the tyre. Forming the elastomeric composition is carried out at the shear rate. The elastomeric composition comprises the at least one additive.
Patent DE-60310905-T2 (DE)
Inventor: HEPLER L
IPC: H04B1/707
Filed: 2003-04-15
Granted: 2007-10-25
Abstract: A physical layer transport composite processing system used in a wireless communication system. A plurality of interconnected processing blocks are provided. The blocks are interconnected by a read data bus, a write data bus and a control bus. The blocks include a transport channel processing block (305,307), a composite channel processing block (303,309) and a chip rate processing block (301,311). At least two of the blocks are capable of processing data for a plurality of wireless formats. A first set of parameters is programmed into the blocks for a particular wireless mode. The blocks are operated to process data in the particular wireless format mode.
Patent DE-60317204-T2 (DE)
Inventor: ALLERMANN GERD A
IPC: C08L23/08
Filed: 2003-07-25
Granted: 2008-08-07
Abstract: Crosslinkable or crosslinked polymer compositions are provided, the compositions including a copolymer of ethylene and C<SUB>3 </SUB>to C<SUB>12 </SUB>alpha-olefin comonomer, the copolymer having a CDBI of at least 70%, a melt index I<SUB>2.16 </SUB>of from 0.1 to 15 g/10 min, a density of from 0.910 to 0.940 g/cm<SUP>3</SUP>, a melt index ratio I<SUB>21.6</SUB>/I<SUB>2.16 </SUB>of from 30 to 80, and an Mw/Mn ratio of from 2.5 to 5.5; and a silane grafting composition including a silane compound and a free radical initiator; or reaction products thereof. The crosslinkable or crosslinked compositions are particularly suitable for electrical applications, such as in insulating, semiconducting or jacketing layers of power cables, telecommunications cables, and combined power/telecommunications cables.
Patent DE-68918036-T2 (DE)
Inventor: KLAVENESS JO
IPC: A61P31/12
Filed: 1989-10-05
Granted: 1995-01-26
Abstract: Compounds of formula (I) <CHEM>  wherein Y<1> is a hydrogen atom or an acyl or acyloxyalkyl group;  Z is a hydrogen atom or an azido group; and X is a purine or pyrimidine base or an ester, amide or acyloxyalkyl, derivative thereof. The compounds have antiviral activity.
Patent DE-68918128-T2 (DE)
Inventor: DEMEESTER JACQUES
IPC: A61B19/00
Filed: 1989-01-06
Granted: 1995-03-09
Abstract: Hair plucking apparatus comprising a rotating plucking roller formed by a series of blades disposed side by side. The blades (5a, 5b) of this roller are mounted in a movable manner on their drive shaft (6) in order to be able to pivot about an axis perpendicular to this shaft. It is furthermore provided with mechanical means for operating these blades, which are capable of causing, at least once per revolution of the roller (4), the pivoting of these blades (5a, 5b), one in one direction and the following one in the opposite direction, each about a separate axis (x.x') perpendicular to the drive shaft. In this way the tightening of two adjacent blades against each other is obtained at the working surface and consequently the gripping of hairs between these blades in order to pluck them. 
<IMAGE>
Patent DE-68925368-T2 (DE)
Inventor: FRETWELL PERCY
IPC: B60P1/44
Filed: 1989-11-03
Granted: 1996-08-14
Abstract: A vehicle lift for stowing beneath the floor of a vehicle includes rails (83, 84) in which can move structure (11). A platform (27) is pivoted to the outer pivots (23a, 24a) of two parallelogram arrangements (20) whose inner pivots (23, 24) are with structure (11). A ram (34) is pivoted between the structure (11) and structure including plates (30, 31) pivoted at (32, 33) on axis (34) to the structure (11). The pivots (32, 33) are coaxial with pivots (23) and the ram is pivoted to plates (30, 31) at a location spaced from axis (34). The platform can be raised and lowered when the lift is not stowed. Arrangements are described in which the lift is stowed in an inclined position; in which the platform can form a step; in which the parallelograms are modified to alter the inclination of the platform. <IMAGE>
Patent DE-68926418-T2 (DE)
Inventor: CASARA PATRICK
IPC: A61P35/00
Filed: 1989-06-28
Granted: 1996-09-19
Abstract: This invention relates to novel chemical compounds useful as S-adenosylmethionine decarboxylase inhibitors, of the formula   H2N-Q- @-Al wherein Al represents 5'-deoxyadenosyl.      represents adenosinyl, R represents H, methyl or ethyl and Q represents moieties of formulae Ia to If depicted as follows: <CHEM>   <CHEM>   <CHEM> wherein R1 is H or F, n is 1 or 2, V1 is H or CH3, V2 is H or COOH, and each of W, X, Y, and Z are H, F, Cl or Br. To the processes useful for their preperation and to their use in the treatment of a variety of condition and disease states associated with a rapid proliferation of cell growth.
Patent DE-68927819-T2 (DE)
Inventor: BARDISA SANTACREU JUAN
IPC: F42B12/48
Filed: 1989-10-14
Granted: 1997-08-21
Abstract: A smoke-producing projectile for riot control comprises three or more independent smoke-producing cylinders (5), which are dispersed by combustion gas pressure.
Patent DE-69012412-T2 (DE)
Inventor: KESSLER JUERGEN
IPC: F15B15/26
Filed: 1990-04-05
Granted: 1995-02-16
Abstract: In a positioning device, e. g. a blockable gas spring (10), a piston rod (12) extends inwards and outwards of a cylinder (11) in axial direction. The piston rod (12) is connected with a piston within the cylinder (11). The piston provides a passage (12b) between two working chambers (11a, 11b) on both axial sides of the piston. A valve (12c) is allocated to this passage (12b). The valve (12c) is actuated by an elongate actuating member (14) extending axially within a channel (12f) of the hollow piston rod (12). The exit (12h) of the channel (12f) is sealingly closed, such as to prevent the entrance of agressive media into the channel (12f).
Patent DE-69020781-T2 (DE)
Inventor: PELLICCIARI ROBERTO
IPC: C07J9/00
Filed: 1990-04-11
Granted: 1995-11-30
Abstract: Compounds of general formula I <CHEM> wherein R1 is hydrogen or hydroxy, and the hydroxy group at the 7-position can be either in or  beta  configuration, are valuable in human therapy. Compounds I can be prepared by reacting with succinic acid carboanions the corresponding derivatives which have previously been protected, and subsequently deprotecting and decarboxylating them.
Patent DE-69023400-T2 (DE)
Inventor: GIANNESSI FABIO
IPC: C07D207/273
Filed: 1990-07-10
Granted: 1996-05-02
Abstract: (Pyrrolidin-2-one-1-yl)acetamides of general formula (I) <CHEM> wherein R is hydrogen or hydroxyl, R1 is hydrogen, R2 is selected from the group consisting of:  2-aminoethyl,  2-(N,N-diisopropyl) aminoethyl,  3-(pyrrolidin-2-one-1-yl) propyl,  2-[N-(pyrrolidin-2-one-d1-yl) acetyl] aminoethyl,  2-hydroxyethyl,  (glycerophosphorylethanolamino) carbonylmethyl,  1-trimethylammonium-3-carboxy-2-propyloxy-carbonylmethyl chloride,  (prolinol-1-yl) carbonylmethyl,  1-trimethylammonium-3-carboxyisopropyl), and  3-pyridylcarbamide; or R1 and R2, taken together, are such as to form a cycle of formula   <CHEM> wherein R3 is selected from the group consisting of phenyl substituted with halogens or halogen-substituted lower (C1-C4) alkyls and 4-morpholinocarbonylmethyl are potent enhancers of learning and memory. Orally or parenterally administrable pharmaceutical compositions in unit dosage form comprise from about 100 to 500 mg of one of the compound of formula (I).